The company doses first patient in US study of Deraphan, as Dolby Ventures joins €53M Series B to support neuropsychiatric innovation
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The system is powered by BrainSense technology, which has received approval from USFDA
Milestone marks a major leap toward real-time, personalised neuromodulation therapy as India’s Parkinson’s burden rises sharply
Punya Salila Srivastava commends sanitation, waste management and infection control measures, while inaugurating a new G+9 undergraduate girls’ hostel
The nationwide campaign, running from April 9–23 highlights the first 1,000 days, nutrition, responsive caregiving and play-based learning as critical pillars for children
STADA will market and distribute two EMA approved biosimilars developed by CuraTeQ in select European Union territories
The study showed a 76% complete response (CR) rate at 12 months, rising to 95% at any time for high-risk NMIBC patients
DiaMedica said it plans to launch the trial later in 2026
Built on the Percept Platform and enhanced with BrainSense technology, the system can adjust stimulation levels in real time, responding to brain signals without manual intervention
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
